Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells

SIMPLE SUMMARY: Triple negative breast cancer is a disease with limited treatment options and the poorest outcome across all breast cancer subtypes, thus the need for new effective therapies is high. We recently found that navitoclax displays synergistic anti-proliferative and apoptotic activities w...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancers (Basel)
Главные авторы: Marczyk, Michal, Patwardhan, Gauri A., Zhao, Jun, Qu, Rihao, Li, Xiaotong, Wali, Vikram B., Gupta, Abhishek K., Pillai, Manoj M., Kluger, Yuval, Yan, Qin, Hatzis, Christos, Pusztai, Lajos, Gunasekharan, Vignesh
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7563413/
https://ncbi.nlm.nih.gov/pubmed/32911681
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12092551
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы